Broadfin Capital as of Dec. 31, 2016
Portfolio Holdings for Broadfin Capital
Broadfin Capital holds 61 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Pharma | 12.1 | $109M | 6.8M | 16.18 | |
| Progenics Pharmaceuticals | 8.6 | $77M | 9.0M | 8.64 | |
| Retrophin | 6.9 | $62M | 3.3M | 18.93 | |
| Heron Therapeutics (HRTX) | 5.7 | $51M | 3.9M | 13.10 | |
| Flamel Technologies | 5.1 | $46M | 4.4M | 10.39 | |
| Antares Pharma | 3.4 | $30M | 13M | 2.33 | |
| Aratana Therapeutics | 3.0 | $27M | 3.7M | 7.18 | |
| La Jolla Pharmaceuticl Com Par | 2.9 | $27M | 1.5M | 17.53 | |
| Endo International (ENDPQ) | 2.9 | $26M | 1.6M | 16.47 | |
| Recro Pharma (SCTL) | 2.8 | $25M | 3.1M | 8.06 | |
| AngioDynamics (ANGO) | 2.8 | $25M | 1.5M | 16.87 | |
| Teva Pharmaceutical Industries (TEVA) | 2.6 | $24M | 648k | 36.25 | |
| Aralez Pharmaceuticals | 2.4 | $21M | 4.8M | 4.41 | |
| Lion Biotechnologies | 2.0 | $18M | 2.6M | 6.95 | |
| Aevi Genomic | 1.9 | $18M | 3.4M | 5.18 | |
| Noveliontherapeuti.. | 1.8 | $16M | 1.9M | 8.42 | |
| Medicines Company | 1.6 | $15M | 436k | 33.94 | |
| Veracyte (VCYT) | 1.5 | $14M | 1.8M | 7.74 | |
| Derma Sciences | 1.5 | $13M | 2.6M | 5.20 | |
| Teligent | 1.4 | $13M | 1.9M | 6.61 | |
| Acorda Therapeutics | 1.3 | $12M | 644k | 18.80 | |
| Paratek Pharmaceuticals | 1.3 | $12M | 786k | 15.40 | |
| Ignyta | 1.3 | $12M | 2.3M | 5.30 | |
| DURECT Corporation | 1.3 | $11M | 8.5M | 1.34 | |
| Advaxis | 1.2 | $11M | 1.5M | 7.16 | |
| Pacira Pharmaceuticals (PCRX) | 1.1 | $9.7M | 301k | 32.30 | |
| BioDelivery Sciences International | 1.1 | $9.4M | 5.4M | 1.75 | |
| Zogenix | 1.0 | $9.3M | 766k | 12.15 | |
| C.R. Bard | 1.0 | $9.0M | 40k | 224.65 | |
| Egalet Corporation note 5.50% 4/1/20 | 1.0 | $8.9M | 10M | 0.89 | |
| Amarin Corporation (AMRN) | 1.0 | $8.7M | 2.8M | 3.08 | |
| Zimmer Holdings (ZBH) | 1.0 | $8.6M | 84k | 103.20 | |
| Catalyst Pharmaceutical Partners (CPRX) | 1.0 | $8.6M | 8.2M | 1.05 | |
| Seaspine Holdings | 1.0 | $8.7M | 1.1M | 7.90 | |
| Endologix | 0.9 | $8.6M | 1.5M | 5.72 | |
| Corium Intl | 0.9 | $7.8M | 1.9M | 4.06 | |
| Strongbridge Bioph shs usd | 0.8 | $6.9M | 2.9M | 2.40 | |
| Idera Pharmaceuticals | 0.7 | $6.6M | 4.4M | 1.50 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.7 | $5.9M | 563k | 10.40 | |
| Adma Biologics (ADMA) | 0.6 | $5.7M | 1.1M | 5.12 | |
| Medtronic (MDT) | 0.6 | $5.3M | 75k | 71.23 | |
| Glaukos (GKOS) | 0.5 | $4.8M | 141k | 34.30 | |
| Scynexis | 0.5 | $4.7M | 1.5M | 3.19 | |
| Alcobra | 0.5 | $4.3M | 2.1M | 2.10 | |
| Aviragen Therapeutics | 0.5 | $4.3M | 3.5M | 1.23 | |
| Egalet | 0.5 | $4.3M | 556k | 7.65 | |
| Nexvet Biopharma Pub Ltd Co ord | 0.5 | $4.2M | 1.1M | 3.73 | |
| Mirati Therapeutics | 0.4 | $3.9M | 826k | 4.75 | |
| Tenax Therapeutics | 0.4 | $3.8M | 2.0M | 1.95 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.4 | $3.6M | 16M | 0.23 | |
| Nevro (NVRO) | 0.3 | $3.1M | 43k | 72.66 | |
| Novadaq Technologies | 0.3 | $2.9M | 407k | 7.09 | |
| Mediwound Ltd cmn | 0.3 | $2.9M | 633k | 4.58 | |
| Redhill Biopharma Ltd cmn | 0.3 | $2.6M | 252k | 10.46 | |
| Contrafect | 0.3 | $2.5M | 1.4M | 1.75 | |
| Palatin Technologies | 0.2 | $2.0M | 3.8M | 0.51 | |
| Cogentix Medical | 0.2 | $1.5M | 754k | 2.01 | |
| Trupanion (TRUP) | 0.1 | $1.0M | 67k | 15.52 | |
| Windtree Therapeutics | 0.1 | $972k | 778k | 1.25 | |
| Dextera Surgical | 0.1 | $803k | 836k | 0.96 | |
| Strata Skin Sciences Incorporated | 0.1 | $423k | 961k | 0.44 |
